Expression of Diaphragmatic Myostatin and Correlation with Apoptosis in Rats with Chronic Obstructive Pulmonary Disease

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2018 Feb 20

PMID 29456636

Citations 9

Authors

Xu Zhou

Daijiao Yi

Yanhong Wu

Xinghua Pei

Haiming Yu

Yanhong Chen

Yu Jiang

Wenpu Li

Affiliations

Soon will be listed here.

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation and loss of lung function. The present study aimed to investigate the diaphragmatic protein expression of myostatin and its correlation with apoptosis in a rat model of CPOD. Sprague Dawley rats were randomly divided into a control group and a COPD group, the latter of which were exposed to cigarette smoke to build a rat model of COPD. The validity of the COPD model was evaluated by assessment of lung function and histopathological analysis. Diaphragmatic myostatin expression and apoptosis were measured by western blot and terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling, respectively. The rat model of COPD was efficiently established by cigarette smoke exposure. Diaphragmatic myostatin expression and apoptotic index in COPD rats were obviously increased as compared with that in the control animals. A positive correlation between diaphragmatic myostatin expression and apoptotic index was identified (r=0.857). Diaphragmatic myostatin overexpression in rats with COPD may promote diaphragmatic apoptosis and atrophy, leading to diaphragm weakness and respiratory muscle dysfunction, which is involved in the pathology of COPD.

Citing Articles

Revisiting Skeletal Muscle Dysfunction and Exercise in Chronic Obstructive Pulmonary Disease: Emerging Significance of Myokines.

Han L, Li P, He Q, Yang C, Jiang M, Wang Y Aging Dis. 2024; 15(6):2453-2469.

PMID: 38270119 PMC: 11567253. DOI: 10.14336/AD.2023.1125.

Dysregulated myokines and signaling pathways in skeletal muscle dysfunction in a cigarette smoke-induced model of chronic obstructive pulmonary disease.

Zhang L, Li C, Xiong J, Chang C, Sun Y Front Physiol. 2022; 13:929926.

PMID: 36091368 PMC: 9454092. DOI: 10.3389/fphys.2022.929926.

As a Modulator, Multitasking Roles of SIRT1 in Respiratory Diseases.

Zhou Y, Zhang F, Ding J Immune Netw. 2022; 22(3):e21.

PMID: 35799705 PMC: 9250864. DOI: 10.4110/in.2022.22.e21.

Myostatin is involved in skeletal muscle dysfunction in chronic obstructive pulmonary disease via Drp-1 mediated abnormal mitochondrial division.

Tan Z, Zhao M, Li J, Li S, Zhu S, Yao X Ann Transl Med. 2022; 10(4):162.

PMID: 35280400 PMC: 8908114. DOI: 10.21037/atm-22-377.

Effect of Oxidative Stress on Diaphragm Dysfunction and Exercise Intervention in Chronic Obstructive Pulmonary Disease.

Zhang B, Li P, Li J, Liu X, Wu W Front Physiol. 2021; 12:684453.

PMID: 34163375 PMC: 8215263. DOI: 10.3389/fphys.2021.684453.

References

Margaritopoulos G, Vasarmidi E, Jacob J, Wells A, Antoniou K . Smoking and interstitial lung diseases. Eur Respir Rev. 2015; 24(137):428-35. PMC: 9487692. DOI: 10.1183/16000617.0050-2015. View

Elkasrawy M, Hamrick M . Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J Musculoskelet Neuronal Interact. 2010; 10(1):56-63. PMC: 3753581. View

Hillas G, Nikolakopoulou S, Hussain S, Vassilakopoulos T . Antioxidants and mucolytics in COPD management: when (if ever) and in whom?. Curr Drug Targets. 2012; 14(2):225-34. DOI: 10.2174/1389450111314020007. View

Testelmans D, Crul T, Maes K, Agten A, Crombach M, Decramer M . Atrophy and hypertrophy signalling in the diaphragm of patients with COPD. Eur Respir J. 2009; 35(3):549-56. DOI: 10.1183/09031936.00091108. View

Fricker M, Deane A, Hansbro P . Animal models of chronic obstructive pulmonary disease. Expert Opin Drug Discov. 2014; 9(6):629-45. DOI: 10.1517/17460441.2014.909805. View

Jiang Y, Gao M, Wang W, Lang Y, Tong Z, Wang K . Sinomenine hydrochloride protects against polymicrobial sepsis via autophagy. Int J Mol Sci. 2015; 16(2):2559-73. PMC: 4346851. DOI: 10.3390/ijms16022559. View

Barreiro E, Ferrer D, Sanchez F, Minguella J, Marin-Corral J, Martinez-Llorens J . Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD. J Appl Physiol (1985). 2011; 111(3):808-17. DOI: 10.1152/japplphysiol.01017.2010. View

Wouters E . Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005; 2(1):26-33. DOI: 10.1513/pats.200408-039MS. View

Amthor H, Huang R, McKinnell I, Christ B, Kambadur R, Sharma M . The regulation and action of myostatin as a negative regulator of muscle development during avian embryogenesis. Dev Biol. 2002; 251(2):241-57. DOI: 10.1006/dbio.2002.0812. View

10.

Yang W, Chen Y, Zhang Y, Wang X, Yang N, Zhu D . Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression. Cancer Res. 2006; 66(3):1320-6. DOI: 10.1158/0008-5472.CAN-05-3060. View

11.

Sauleda Roig J . [Clinical consequences of muscle dysfunction in chronic obstructive pulmonary disease]. Nutr Hosp. 2006; 21 Suppl 3:69-75. View

12.

Hayot M, Rodriguez J, Vernus B, Carnac G, Jean E, Allen D . Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli. Mol Cell Endocrinol. 2010; 332(1-2):38-47. DOI: 10.1016/j.mce.2010.09.008. View

13.

Andersen M, Parham A, Waldrep J, McKenzie W, Dhand R . Alveolar fractal box dimension inversely correlates with mean linear intercept in mice with elastase-induced emphysema. Int J Chron Obstruct Pulmon Dis. 2012; 7:235-43. PMC: 3324997. DOI: 10.2147/COPD.S26493. View

14.

Levine S, Nguyen T, Kaiser L, Rubinstein N, Maislin G, Gregory C . Human diaphragm remodeling associated with chronic obstructive pulmonary disease: clinical implications. Am J Respir Crit Care Med. 2003; 168(6):706-13. DOI: 10.1164/rccm.200209-1070OC. View

15.

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

16.

Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N . Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab. 2003; 285(2):E363-71. DOI: 10.1152/ajpendo.00487.2002. View

17.

Morris Z, Coz A, Starosta D . An isolated reduction of the FEV3/FVC ratio is an indicator of mild lung injury. Chest. 2013; 144(4):1117-1123. DOI: 10.1378/chest.12-2816. View

18.

McPherron A, Lawler A, Lee S . Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997; 387(6628):83-90. DOI: 10.1038/387083a0. View

19.

Sartori R, Gregorevic P, Sandri M . TGFβ and BMP signaling in skeletal muscle: potential significance for muscle-related disease. Trends Endocrinol Metab. 2014; 25(9):464-71. DOI: 10.1016/j.tem.2014.06.002. View

20.

Plataki M, Tzortzaki E, Rytila P, Demosthenes M, Koutsopoulos A, Siafakas N . Apoptotic mechanisms in the pathogenesis of COPD. Int J Chron Obstruct Pulmon Dis. 2007; 1(2):161-71. PMC: 2706617. DOI: 10.2147/copd.2006.1.2.161. View